Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Open in API
Filings indexed 643 across all filing types
Latest filing 2024-08-22 Regulatory Filings
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Observe Medical - First order from South America
Regulatory Filings Classification · 87% confidence The document is a short press release announcing a specific business event: receiving the first order from a distributor in South America for their UnoMeter 500 products. This is a material business update, but it does not fit the definitions for a formal financial report (10-K, IR, ER), a management change (MANG), or a capital event (CAP, SHA). It is a general operational/business announcement. Since it is not a formal regulatory filing like a 10-K or a specific financial disclosure, and it is not announcing the release of a larger report (RPA), the most appropriate general category for a non-standard, material business update that doesn't fit elsewhere is 'Regulatory Filings' (RNS), which serves as a broad category for miscellaneous announcements.
2024-08-22 English
Invitation to Observe Medical ASA's first half year 2024 presentation and Q&A
Report Publication Announcement Classification · 98% confidence The document is a short announcement (2534 characters) stating that Observe Medical will release its results for the first half year 2024 on August 26, 2024, and invites observers to a presentation and Q&A session. It explicitly mentions that the presentation will be published on NewsWeb and the Company's website. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report, rather than containing the full report itself, should be classified as a Report Publication Announcement (RPA). The content is an invitation and notice about the upcoming release of the H1 2024 results, not the results document (which would likely be an IR or ER).
2024-08-19 English
Invitation to Observe Medical ASA's first half year 2024 presentation and Q&A
Report Publication Announcement Classification · 98% confidence The document is an 'Invitation to Observe Medical ASA's first half year 2024 presentation and Q&A'. It explicitly states that the company 'will release its results for the first half year 2024' on a specific date and announces the time and method (webcast/in-person) for observing this presentation and Q&A session. This document is not the actual financial report (which would be an IR or ER), but rather the announcement about the upcoming event where the results will be discussed. According to Rule 2 (The 'MENU VS MEAL' Rule), if a document announces the publication or presentation of a report, it should be classified as a Report Publication Announcement (RPA). The content is short and serves purely to invite stakeholders to an event related to the release of interim results.
2024-08-19 English
Jørgen Mann appointed permanent CEO of Observe Medical
Board/Management Information Classification · 100% confidence The document announces the permanent appointment of Jørgen Mann as the CEO of Observe Medical ASA. This is a direct announcement regarding a change in senior management personnel. Based on the definitions, this aligns perfectly with the 'Board/Management Information' category (Code: MANG). The document is short and contains no financial results or regulatory filing headers, confirming it is an announcement about management, not a formal report like 10-K or ER.
2024-08-13 English
Jørgen Mann appointed permanent CEO of Observe Medical
Board/Management Information Classification · 100% confidence The document text is a short announcement dated August 13, 2024, stating that Jørgen Mann has been appointed as the permanent Chief Executive Officer (CEO) of Observe Medical ASA, succeeding his interim role. This directly concerns a change in senior management personnel. Based on the provided definitions, this aligns perfectly with the 'Board/Management Information' category.
2024-08-13 English
Financial calendar
Report Publication Announcement Classification · 98% confidence The document text is extremely short (391 characters) and explicitly details a change in the publication date for the 'Half-yearly Report' (Interim Report) for the first half of 2024. It announces *when* a report will be published, rather than containing the report itself. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports. It is not the Interim Report (IR) itself, nor is it a general regulatory filing (RNS) since RPA is more specific.
2024-08-12 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.